ir.xxiicentury.com22nd Century Group, Inc. - Investor Relations

Overview News Events & Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Analyst Coverage Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Executive Management Board of Directors ESG Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Investor Relations Overview News Events & Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Analyst Coverage Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Executive Management Board of Directors ESG Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Corporate Overview 22nd Century Group, Inc. is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. Our primary mission in tobacco is to reduce the harm caused by smoking by bringing our reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes – to adult smokers in the U.S. and international markets. Our mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants with valuable cannabinoid profiles and desirable agronomic traits. Why Invest Commercializing disruptive products utilizing advanced alkaloid plant technologies to improve health VLN® 95% reduced nicotine content cigarettes are the world’s first and only combustible cigarettes to receive Modified Risk Tobacco Product (MRTP) authorization from the FDA North America’s largest CDMO provider of hemp-derived active ingredients for the pharmaceutical and consumer goods industries Scaling revenue in two growth business units to achieve cash positive operations Latest News View all news Latest Presentation Latest Events View All Events Latest Quarterly Reports View All Financial Reports Contact Us Company 22nd Century Group, Inc. 500 Seneca Street, Suite 507 Buffalo, NY 14204 Investor Relations Matt Kreps 22nd Century Group Investor Relations contact us by phone 214-597-8200 contact us by email [email protected] Transfer Agent Continental Stock & Transfer Company 1 State Street, 30th Floor New York, NY 10004 contact us by phone 212-509-4000 contact us by email [email protected] Quick Links SEC Filings Investor FAQs Information Request Form Investor Email Alerts To opt-in for investor email alerts, please enter your email address in the field and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At 22nd Century Group, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section. If you experience any issues with this process, please contact us for further assistance. By providing your email address, you are providing consent to 22nd Century Group, Inc. to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Events & Presentations UnsubscribeEmail Alert Sign Up Confirmation Privacy Policy / CCPA Site Map © 22nd Century Group, Inc. - All rights reserved Powered By Q4 Inc. 5.122.0.3 (opens in new window) Opens in new...